Effectiveness Comparison of Drug and Non-Drug Therapy for Agitation in Alzheimer's Disease
Data Collection
Aberrant Motor Behavior in Dementia+16
+ Alzheimer Disease
+ Behavior
Treatment Study
Summary
Agitation is a common issue, affecting up to 90% of Alzheimer's Disease (AD) patients. It includes symptoms like verbal and physical aggression, irritability, wandering, and restlessness, making home care challenging. Two commonly prescribed drugs for agitation in AD are Trazodone and Haldol. There's also a non-drug approach called behavior management, which has shown effectiveness in reducing agitation. However, it's still unknown which method, drug or non-drug, is most effective for treating agitation in AD patients. The Alzheimer's Disease Cooperative Study, funded by the National Institute on Aging, is conducting a treatment program across 21 sites in 16 states to find the best treatment for agitation in AD patients.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 16 locations
University of California, Los Angeles
Los Angeles, United StatesOpen University of California, Los Angeles in Google MapsUniversity of California, San Diego
San Diego, United StatesUniversity of Miami
Miami, United StatesUniversity of South Florida
Tampa, United States